summary: Natalizumab is a new medication for MS, which is very effective at reducing inflammation but can have serious side effects. In this pathological study the effects of natalizumab on certain areas of the brain were investigated and differences in the immune cells were found, which might partly explain the prolonged effects of the medication.

authors: Martin MD, Cravens PD, Winger R, Frohman EM, Racke MK, Eagar TN, Zamvil SS, Weber MS, Hemmer B, Karandikar NJ, Kleinschmidt-Demasters BK, Stüve O

source: Arch Neurol. 2008 Oct 13

weblink: click here

category: Immunology

related research news: click here

glossary: